Aktie A2QB49 ALPA HEAL
Zu einer Liste hinzufügen
Um diese Funktionalität nutzen zu können, müssen Sie Mitglied sein
EinloggenRegistrieren
Inaktiver Wert

Andere Sprachen ALPA HEAL

Aktien

A2QB49

US0207511033

AHAC

Andere Sprachen

Suchen
Ergebnisse ansehen
Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!
100% kostenlose Registrierung
ALPA HEAL : Report of Independent Registered Public Accounting Firm (Form 8-K)
Alpha Healthcare Acquisition : Humacyte Announces Successful Closing of Business Combination with Alpha Healthcare Acquisition Corp.
Alpha Healthcare Acquisition Corp.(NasdaqCM:AHAC) dropped from NASDAQ Composite Index
Humacyte, Inc. completed the acquisition of Alpha Healthcare Acquisition Corp. from a group of shareholders in a reverse merger transaction.
Alpha Healthcare Acquisition : Announces Shareholder Approval of Business Combination with Humacyte (Form 8-K)
ALPHA HEALTHCARE ACQUISITION CORP. : Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits (form 8-K)
Alpha Healthcare Acquisition : Receives Shareholder Approval for Humacyte Deal
Alpha Healthcare Acquisition : Humacyte Announces Addition of Chief Commercial Officer and Integration of Commercial-Scale Manufacturing into Clinical Trial Programs (Form 8-K)
ALPHA HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
ALPHA HEALTHCARE ACQUISITION : Management's Discussion and Analysis of Financial Condition and Results of Operations (form 10-Q)
Alpha Healthcare Acquisition Corp. Reports Earnings Results for the Second Quarter Ended June 30, 2021
Alpha Healthcare Acquisition : Humacyte Announces Publication of In Vivo Data on Biovascular Pancreas Transplantation for the Treatment of Type 1 Diabetes
Alpha Healthcare Acquisition : Sets August 24, 2021 for Special Shareholder Meeting to Vote on Humacyte Business Combination (Form 8-K)
ALPHA HEALTHCARE ACQUISITION CORP. : Other Events, Financial Statements and Exhibits (form 8-K)
Alpha Healthcare Acquisition : Humacyte Presents Potential of Functional Lung Engineering at Janelia R3 – Replace, Repair, Regenerate Planning Workshop
Alpha Healthcare Acquisition : Humacyte to Provide Investor Update on June 7 (Form 8-K)
ALPHA HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
Alpha Healthcare Acquisition : Humacyte Announces Presentation by Principal Investigator Highlighting Clinical Experience with HAVs at Vascular Access Society of the Americas 2021 Spring Conference (Form 8-K)
ALPHA HEALTHCARE ACQUISITION CORP. : Regulation FD Disclosure, Other Events, Financial Statements and Exhibits (form 8-K)
Alpha Healthcare Acquisition : Laboratory and pre-clinical models of whole-lung engineering further inform roadmap for building a functional lung alveolus (Form 8-K)
Keine Ergebnisse zu dieser Suche
Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Filter

Suchen

Datum der Veröffentlichung

Vom

Bis

  1. Börse
  2. Aktien
  3. A2QB49 Aktie
  4. Nachrichten ALPA HEAL
  5. Andere Sprachen